1814
H. Tanaka et al. / Tetrahedron Letters 53 (2012) 1812–1815
NBoc
NBoc
OH
NHTFA
O
H
3
i
5
iii
O
O
H
4
C13H27
NHTFA
C13H27
H
R
Ph
O
1
O
2
O
O
12
H
13: R = H
15 (11% from 12)
Ph
ii
14: R = C13H27
iv
NHTFA
HO
C13H27
5
OH
(67%)
Scheme 3. Synthesis of sphingosine acceptor 5. (i) vinylmagnesium bromide/THF, ꢀ78 °C, 2 h; (ii) 1-pentadecene, Grubbs 2nd generation catalyst/CH2Cl2, reflux, 4 h; (iii) (a)
aq. AcOH, 50 °C, 13 h; (b) TFA/CH2Cl2, rt, 2 h; (c) TFA2O, Et3N, MeOH/CH2Cl2, rt, 48 h; (d) benzaldehyde dimethyl acetal, TsOH monohydrate/MeCN, rt, 1 h; (iv) aq. AcOH, rt to
50 °C, 38 h.
TMSOTf
(0.2 equiv.)
3 Å MS
AcO
AcO
AcO
AcO
OAc
O
OAc
O
OBz
O
OBz
O
NHTFAc
OH
NHTFAc
O
S
S
O
C13H27
O
C13H27
4
+
5
BzO
BzO
AcO
AcO
CH2Cl2
-10 °C to RT
18 h
+
(1.2 equiv.) (1.0 equiv.)
BzO
BzO
16
17
O
OBz
(22%)
(23%)
BzO
OAc
O
AcO
AcO
OBz
S
AcO
Scheme 4. Coupling of disaccharide donor 4 with sphingosine acceptor 5.
HO
HO
O
OH
O
OH
O
HO OH
AcHN
OH
O
R
i
iii
HN
16
HO
S
O
HO
O
C13H27
HO
HO
HO
18
HO
OH
COOH
OH
3: R = H
2: R =
HO
OH
O
Me2N
O
NMe2
iv
HO
ii
HO
O
OH
O
COO
HO
HO
19
O
HN
O
Scheme 5. Deprotection, labeling with 6-TMR-b-Ala, and enzymatic reactions. (i) NaOMe/MeOH, rt, 4 days; (ii) 6-TMR-b-Ala NHS ester, DIEA/DMF, rt, 24 h; (iii) CMP-Neu5Ac,
(2,3)-sialyltransferase (MalE fusion protein from Campylobacter jejuni), MOPS buffer (pH 7.5) containing MnCl2 and 5% (v/v) DMSO; (iv) UDP-Gal, (1,4)-galactosyltrans-
ferase (Neisseria meningitidis), MOPS buffer (pH 7.0) containing MnCl2, BSA, DTT and 5% (v/v) DMSO.
a
a
Hindsgaul, O.; Palcic, M. M.; Prendergast, J.; Schnaar, R. L.; Dovichi, N. J. Anal.
Chem. 2011, 83, 2748–2753; (c) Krylov, S. N.; Zhang, Z.; Chan, N. W.; Arriaga, E.;
Palcic, M. M.; Dovichi, N. J. Cytometry 1999, 37, 14–20.
References and notes
1. Karlsson, K.-A. Ann. Rev. Biochem. 1989, 58, 309–350.
2. Hakomori, S. Cancer Res. 1996, 56, 5309–5318.
3. Hakomori, S. Adv. Exp. Med. Biol. 2001, 491, 369–402.
4. Taylor, M. E.; Drickamer, K. Introduction to Glycobiology, second Ed.; Oxford
University Press: Oxford, UK, 2003. pp. 74–75.
5. Birkle, S.; Zeng, G.; Gao, L.; Yu, R. K.; Aubry, J. Biochimie 2003, 85, 455–463.
6. Marquardt, T.; Denecke, J. Eur. J. Pediatr. 2003, 162, 359–379.
7. Kolter, T.; Sandhoff, K. Angew. Chem., Int. Ed. 1999, 8, 1532–1568.
8. Albrecht, B.; Pütz, U.; Schwarzmann, G. Carbohydr. Res. 1995, 276, 289–308.
9. Schwarzmann, G.; Hofmann, P.; Pütz, U. Carbohydr. Res. 1997, 304, 43–52.
10. Xia, C.; Zhou, D.; Liu, C.; Lou, Y.; Yao, Q.; Zhang, W.; Wang, P. G. Org. Lett. 2006,
8, 5493–5496.
11. (a) Whitmore, C. D.; Hindsgaul, O.; Palcic, M. M.; Schnaar, R. L.; Dovichi, N. J.
Anal. Chem. 2007, 79, 5139–5142; (b) Cohen, D.; Dickerson, J. A.; Whitmore, C.
D.; Turner, E. H.; Palcic, M. M.; Hindsgaul, O.; Dovichi, N. J. Annu. Rev. Anal.
Chem. 2008, 1, 165–190.
13. Larsson, E. A.; Olsson, U.; Whitmore, C. D.; Martins, R.; Tettamanti, G.; Schnaar,
R. L.; Dovichi, N. J.; Palcic, M. M.; Hindsgaul, O. Carbohydr. Res. 2007, 342, 482–
489.
14. Lee, Y. M.; Lee, S.; Jeon, H.; Baek, D. J.; Seo, J. H.; Kim, D.; Kim, S. Synthesis 2011,
867–872.
15. Gamblin, D. P.; Garnier, P.; van Kasteren, S.; Oldham, N. J.; Fairbanks, A. J.;
Davis, B. G. Angew. Chem., Int. Ed. 2004, 43, 828–833.
16. Wang, P.; Fukuda, M.; Seeberger, P. H. Chem. Commun. 2007, 1963–1965.
17. The coupling yield could be improved using acetonitrile as the solvent, see:
Ibatullin, F. M.; Selivanov, S. I.; Shavva, A. G. Synthesis 2001, 419–422.
18. The diastereoselectivity was assigned by 1H NMR spectroscopy of the crude
product: (a) Srivastava, A. K.; Panda, G. Chem. Eur. J. 2008, 14, 4675–4688; (b)
Lankalaplli, R. S.; Ouro, A.; Arana, L.; Gómez-Muñoz, A.; Bittman, R. J. Org. Chem.
2009, 74, 8844–8847.
19. Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953–956.
20. The configuration of cyclic protected sphingosine 15 was confirmed from the
coupling constants (J1ax,2 = J2,3 = approx. 10 Hz, J4,5 = 15.2 Hz).
12. (a) Whitmore, C. D.; Olsson, U.; Larsson, E. A.; Hindsgaul, O.; Palcic, M. M.;
Dovichi, N. J. Electrophoresis 2007, 28, 3100–3104; (b) Dada, O. O.; Essaka, D. C.;